Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD).

Int J Womens Dermatol

Department of Dermatology, University of California, San Francisco, San Francisco, CA, United States.

Published: December 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938892PMC
http://dx.doi.org/10.1016/j.ijwd.2019.08.007DOI Listing

Publication Analysis

Top Keywords

nonsteroid management
4
management residual
4
residual ocular
4
ocular surface
4
surface disease
4
disease dupilumab
4
dupilumab rosdd
4
nonsteroid
1
residual
1
ocular
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!